Shopping Cart 0
Cart Subtotal
AED 0

Oramed Pharmaceuticals Inc (ORMP) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 1376

Details

Oramed Pharmaceuticals Inc (ORMP)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Oramed Pharmaceuticals Inc (Oramed) engages in the research and development of novel pharmaceutical solutions, comprising an oral insulin capsule for the treatment of individuals with diabetes, and orally ingestible capsules or pills for delivery of other polypeptides. It developed a unique proprietary platform technology, Protein Oral Delivery (POD) to transform injectable treatments into oral therapies. The technology allows for the oral delivery of drugs currently administered only by injection. The company tested its technology through various animal and human studies on its two flagship products, ORMD-0801, an orally ingestible insulin capsule; and ORMD-0901, an oral GLP-1 analog (exenatide) capsule. Oramed is headquartered in Jerusalem, Israel.

Oramed Pharmaceuticals Inc Key Recent Developments

Jul 23,2019: Oramed Pharmaceuticals: Departure of Directors or certain officers

Jul 02,2019: Oramed announces Xiaoming Gao joins board of directors

Mar 28,2019: Oramed patent allowed in the U.S. for key aspect of its oral delivery technology

May 30,2018: Oramed Patent Allowed in the US for Oral Administration of Proteins

Feb 28,2018: Oramed Appoints Robert Henry and Jane Reusch to its Scientific Advisory Board

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Oramed Pharmaceuticals Inc-Key Facts

Oramed Pharmaceuticals Inc-Key Employees

Oramed Pharmaceuticals Inc-Key Employee Biographies

Oramed Pharmaceuticals Inc-Major Products and Services

Oramed Pharmaceuticals Inc-History

Oramed Pharmaceuticals Inc-Company Statement

Oramed Pharmaceuticals Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2-Company Analysis

Company Overview

Oramed Pharmaceuticals Inc-Business Description

R&D Overview

Oramed Pharmaceuticals Inc-Corporate Strategy

Oramed Pharmaceuticals Inc-SWOT Analysis

SWOT Analysis-Overview

Oramed Pharmaceuticals Inc-Strengths

Oramed Pharmaceuticals Inc-Weaknesses

Oramed Pharmaceuticals Inc-Opportunities

Oramed Pharmaceuticals Inc-Threats

Oramed Pharmaceuticals Inc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Oramed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Oramed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Oramed Pharmaceuticals Inc, Recent Deals Summary

Section 5-Company's Recent Developments

Jul 23, 2019: Oramed Pharmaceuticals: Departure of Directors or certain officers

Jul 02, 2019: Oramed announces Xiaoming Gao joins board of directors

Mar 28, 2019: Oramed patent allowed in the U.S. for key aspect of its oral delivery technology

May 30, 2018: Oramed Patent Allowed in the US for Oral Administration of Proteins

Feb 28, 2018: Oramed Appoints Robert Henry and Jane Reusch to its Scientific Advisory Board

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Oramed Pharmaceuticals Inc, Performance Chart (2014-2018)

Oramed Pharmaceuticals Inc, Ratio Charts

Oramed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Oramed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Oramed Pharmaceuticals Inc, Key Facts

Oramed Pharmaceuticals Inc, Key Employees

Oramed Pharmaceuticals Inc, Key Employee Biographies

Oramed Pharmaceuticals Inc, Major Products and Services

Oramed Pharmaceuticals Inc, History

Oramed Pharmaceuticals Inc, Subsidiaries

Oramed Pharmaceuticals Inc, Joint Venture

Oramed Pharmaceuticals Inc, Key Competitors

Oramed Pharmaceuticals Inc, Ratios based on current share price

Oramed Pharmaceuticals Inc, Annual Ratios

Oramed Pharmaceuticals Inc, Annual Ratios (Cont...1)

Oramed Pharmaceuticals Inc, Interim Ratios

Oramed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Oramed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Oramed Pharmaceuticals Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Oramed Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Novo Nordisk AS

Midatech Pharma Plc

MannKind Corp

Generex Biotechnology Corp

Emisphere Technologies Inc

Diabetology (Products) Ltd

Biocon Ltd

Company Profile

Company Profile Title

Oramed Pharmaceuticals Inc (ORMP)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Oramed Pharmaceuticals Inc (Oramed) engages in the research and development of novel pharmaceutical solutions, comprising an oral insulin capsule for the treatment of individuals with diabetes, and orally ingestible capsules or pills for delivery of other polypeptides. It developed a unique proprietary platform technology, Protein Oral Delivery (POD) to transform injectable treatments into oral therapies. The technology allows for the oral delivery of drugs currently administered only by injection. The company tested its technology through various animal and human studies on its two flagship products, ORMD-0801, an orally ingestible insulin capsule; and ORMD-0901, an oral GLP-1 analog (exenatide) capsule. Oramed is headquartered in Jerusalem, Israel.

Oramed Pharmaceuticals Inc Key Recent Developments

Jul 23,2019: Oramed Pharmaceuticals: Departure of Directors or certain officers

Jul 02,2019: Oramed announces Xiaoming Gao joins board of directors

Mar 28,2019: Oramed patent allowed in the U.S. for key aspect of its oral delivery technology

May 30,2018: Oramed Patent Allowed in the US for Oral Administration of Proteins

Feb 28,2018: Oramed Appoints Robert Henry and Jane Reusch to its Scientific Advisory Board

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Oramed Pharmaceuticals Inc-Key Facts

Oramed Pharmaceuticals Inc-Key Employees

Oramed Pharmaceuticals Inc-Key Employee Biographies

Oramed Pharmaceuticals Inc-Major Products and Services

Oramed Pharmaceuticals Inc-History

Oramed Pharmaceuticals Inc-Company Statement

Oramed Pharmaceuticals Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2-Company Analysis

Company Overview

Oramed Pharmaceuticals Inc-Business Description

R&D Overview

Oramed Pharmaceuticals Inc-Corporate Strategy

Oramed Pharmaceuticals Inc-SWOT Analysis

SWOT Analysis-Overview

Oramed Pharmaceuticals Inc-Strengths

Oramed Pharmaceuticals Inc-Weaknesses

Oramed Pharmaceuticals Inc-Opportunities

Oramed Pharmaceuticals Inc-Threats

Oramed Pharmaceuticals Inc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Oramed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Oramed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Oramed Pharmaceuticals Inc, Recent Deals Summary

Section 5-Company's Recent Developments

Jul 23, 2019: Oramed Pharmaceuticals: Departure of Directors or certain officers

Jul 02, 2019: Oramed announces Xiaoming Gao joins board of directors

Mar 28, 2019: Oramed patent allowed in the U.S. for key aspect of its oral delivery technology

May 30, 2018: Oramed Patent Allowed in the US for Oral Administration of Proteins

Feb 28, 2018: Oramed Appoints Robert Henry and Jane Reusch to its Scientific Advisory Board

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Oramed Pharmaceuticals Inc, Performance Chart (2014-2018)

Oramed Pharmaceuticals Inc, Ratio Charts

Oramed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Oramed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Oramed Pharmaceuticals Inc, Key Facts

Oramed Pharmaceuticals Inc, Key Employees

Oramed Pharmaceuticals Inc, Key Employee Biographies

Oramed Pharmaceuticals Inc, Major Products and Services

Oramed Pharmaceuticals Inc, History

Oramed Pharmaceuticals Inc, Subsidiaries

Oramed Pharmaceuticals Inc, Joint Venture

Oramed Pharmaceuticals Inc, Key Competitors

Oramed Pharmaceuticals Inc, Ratios based on current share price

Oramed Pharmaceuticals Inc, Annual Ratios

Oramed Pharmaceuticals Inc, Annual Ratios (Cont...1)

Oramed Pharmaceuticals Inc, Interim Ratios

Oramed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Oramed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Oramed Pharmaceuticals Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Oramed Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Novo Nordisk AS

Midatech Pharma Plc

MannKind Corp

Generex Biotechnology Corp

Emisphere Technologies Inc

Diabetology (Products) Ltd

Biocon Ltd